Sun Pharma Advanced Research Co (NSE:SPARC) Cyclically Adjusted Book per Share: ₹6.50 (As of Mar. 2026)


NSE:SPARC Sun Pharma Advanced Research Co Ltd NSE:SPARC
61 GF Score
Price ₹239.37
GF Value ₹4,504.88
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Sun Pharma Advanced Research Co Cyclically Adjusted Book per Share?

Sun Pharma Advanced Research Co NSE:SPARC +0.02% 61 Cyclically Adjusted Book per Share is ₹6.50 as of Mar. 2026. GuruFocus rates NSE:SPARC with a GF Score™ of 61/100 and a GF Value™ of ₹4,504.88 (Possible Value Trap). The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Sun Pharma Advanced Research Co's adjusted book value per share for the three months ended in Mar. 2026 was ₹41.255. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹6.50 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Sun Pharma Advanced Research Co's average Cyclically Adjusted Book Growth Rate was 28.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 4.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Sun Pharma Advanced Research Co was 7.00% per year. The lowest was -2.60% per year. And the median was 4.60% per year.

As of today (2026-07-04), Sun Pharma Advanced Research Co's current stock price is ₹239.37. Sun Pharma Advanced Research Co's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was ₹6.50. Sun Pharma Advanced Research Co's Cyclically Adjusted PB Ratio of today is 36.83.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sun Pharma Advanced Research Co was 75.51. The lowest was 19.20. And the median was 37.45.


Sun Pharma Advanced Research Co  (NSE:SPARC) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Sun Pharma Advanced Research Co's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=239.37/6.50
=36.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Sun Pharma Advanced Research Co was 75.51. The lowest was 19.20. And the median was 37.45.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Sun Pharma Advanced Research Co Cyclically Adjusted Book per Share Related Terms


Sun Pharma Advanced Research Co Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Sun Pharma Advanced Research Co's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sun Pharma Advanced Research Co Cyclically Adjusted Book per Share Chart

Sun Pharma Advanced Research Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.46 5.67 5.71 5.05 6.50

Sun Pharma Advanced Research Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.05 0.00 4.37 0.00 6.50

NSE:SPARC vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Sun Pharma Advanced Research Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sun Pharma Advanced Research Co Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sun Pharma Advanced Research Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Sun Pharma Advanced Research Co's Cyclically Adjusted PB Ratio falls into.


NSE:SPARC
61GF Score
Sun Pharma Advanced Research Co Ltd NSE:SPARC
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sun Pharma Advanced Research Co Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sun Pharma Advanced Research Co's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=41.255/164.2724*164.2724
=41.255

Current CPI (Mar. 2026) = 164.2724.

Sun Pharma Advanced Research Co Quarterly Data

Book Value per Share CPI Adj_Book
201606 0.000 105.961 0.000
201609 10.460 105.961 16.216
201612 0.000 105.196 0.000
201703 6.406 105.196 10.004
201706 0.000 107.109 0.000
201709 5.731 109.021 8.635
201712 0.000 109.404 0.000
201803 7.361 109.786 11.014
201806 0.000 111.317 0.000
201809 8.715 115.142 12.434
201812 0.000 115.142 0.000
201903 11.305 118.202 15.711
201906 0.000 120.880 0.000
201909 5.316 123.175 7.090
201912 0.000 126.235 0.000
202003 -0.711 124.705 -0.937
202006 0.000 127.000 0.000
202009 -1.784 130.118 -2.252
202012 0.000 130.889 0.000
202103 -6.421 131.771 -8.005
202106 0.000 134.084 0.000
202109 0.179 135.847 0.216
202112 0.000 138.161 0.000
202203 1.149 138.822 1.360
202206 0.000 142.347 0.000
202209 -4.310 144.661 -4.894
202212 0.000 145.763 0.000
202303 15.801 146.865 17.674
202306 0.000 150.280 0.000
202309 10.221 151.492 11.083
202312 0.000 152.924 0.000
202403 3.875 153.035 4.160
202406 0.000 155.789 0.000
202409 0.000 157.882 0.000
202412 0.000 158.323 0.000
202503 -6.685 157.552 -6.970
202506 0.000 159.755 0.000
202509 -10.620 162.289 -10.750
202512 0.000 163.281 0.000
202603 41.255 164.272 41.255

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of ₹6.50 mean?
Sun Pharma Advanced Research Co (NSE:SPARC) has a Cyclically Adjusted Book per Share of ₹6.50 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sun Pharma Advanced Research Co and its competitors.
Is Sun Pharma Advanced Research Co's Cyclically Adjusted Book per Share too high?
Sun Pharma Advanced Research Co's current Cyclically Adjusted Book per Share is ₹6.50. Overall, Sun Pharma Advanced Research Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Sun Pharma Advanced Research Co's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Sun Pharma Advanced Research Co's Cyclically Adjusted Book per Share of ₹6.50 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Sun Pharma Advanced Research Co and its competitors. Sun Pharma Advanced Research Co's current Cyclically Adjusted Book per Share is ₹6.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sun Pharma Advanced Research Co stock overvalued right now?
Based on GuruFocus' analysis, Sun Pharma Advanced Research Co (NSE:SPARC) is currently considered Possible Value Trap. The stock's GF Value™ is ₹4,504.88, compared to a current price of ₹239.37 — trading 94.7% below its estimated fair value. The current Cyclically Adjusted Book per Share is ₹6.50. Sun Pharma Advanced Research Co's overall GF Score™ is 61/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Sun Pharma Advanced Research Co (NSE:SPARC), the current Cyclically Adjusted Book per Share is ₹6.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sun Pharma Advanced Research Co (NSE:SPARC) Overvalued in 2026?

Based on GuruFocus' analysis, Sun Pharma Advanced Research Co stock appears to be undervalued. The current stock price of ₹239.37 is trading 94.7% below its estimated GF Value™ of ₹4,504.88. GuruFocus considers Sun Pharma Advanced Research Co to be Possible Value Trap.

Key valuation signals for NSE:SPARC:

  • Cyclically Adjusted Book per Share: ₹6.50
  • GF Value™: ₹4,504.88 vs. price of ₹239.37 (94.7% below fair value)
  • GF Score™: 61/100 with 7 warning signs

No single metric tells the full story. See the NSE:SPARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sun Pharma Advanced Research Co Business Description

Other Exchanges 532872:India
Address Off Mahakali Caves Road, 17-B, Mahal Industrial Estate, Andheri (East), Mumbai, MH, IND, 400093
Sun Pharma Advanced Research Co Ltd is an Indian specialty and generic drug manufacturing company. The company has identified pharmaceuticals research and development as its only reportable segment. The company is focused on drug discovery in focused therapy areas such as cancer and anti-inflammatory treatments. The company considers merger and acquisition investment as a potential component of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities. It derives maximum revenue from India and also has its presence in other countries.
61GF Score

Get the complete analysis for NSE:SPARC

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹239.37
Price
₹4,504.88
GF Value